Author

Alex Mabry

Washington University in St. LouisORCID 0000-0003-1635-8800Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

Jason D. WeberiD· 2 shared Leonard B. MaggiiD· 2 shared Angelina O’Brien· 1 shared Catherine E. Kuzmicki· 1 shared Che-Pei KungiD· 1 shared Emily R. BrameliD· 1 shared Eric C. FreemaniD· 1 shared Gary J. PattiiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Jason D. WeberORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyMolecular and Cellular BiologyPeer-reviewedMay 12, 2025

Elevated type I interferon signaling defines the proliferative advantage of ARF and p53 mutant tumor cells

Alex Mabry, Catherine E. Kuzmicki, Angelina O’Brien…·Jason D. Weber

The paper shows that loss of p53 and ARF increases type I interferon signaling, which drives proliferation and is inhibited by JAK1 inhibitors in tumor cells.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 16, 2025

ADAR1 Regulates Lipid Remodeling to Dictate Ferroptosis Sensitivity

Che-Pei Kung, Nick Terzich, Ma Xenia G. Ilagan…·Jason D. Weber

This study shows ADAR1 protects TNBC cells from ferroptosis by regulating lipid composition, and identifies cobimetinib as a potential therapeutic agent when combined with ADAR1 loss.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky